Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Cai Grau, Morten Høyer, Jacob Lindegaard & Jens Overgaard. (2006) The emerging evidence for Stereotactic Body Radiotherapy. Acta Oncologica 45:7, pages 771-774.
Read now
Read now
Articles from other publishers (11)
Connor W. Barth, Vidhi M. Shah, Lei G. Wang, Anas M. Masillati, Adel Al-Fatease, Syed Zaki Husain Rizvi, Alexander L. Antaris, Jonathan Sorger, Deepa A. Rao, Adam W.G. Alani & Summer L. Gibbs. (2022) A clinically relevant formulation for direct administration of nerve specific fluorophores to mitigate iatrogenic nerve injury. Biomaterials 284, pages 121490.
Crossref
Crossref
Connor W. Barth, Christopher L. Amling & Summer L. Gibbs. (2019) Fluorescent nerve identification in resected human tissue specimens. Fluorescent nerve identification in resected human tissue specimens.
Robert L. Bard. 2014. Image Guided Prostate Cancer Treatments. Image Guided Prostate Cancer Treatments
11
30
.
E W de Bekker-Grob, M C J Bliemer, B Donkers, M-L Essink-Bot, I J Korfage, M J Roobol, C H Bangma & E W Steyerberg. (2013) Patients’ and urologists’ preferences for prostate cancer treatment: a discrete choice experiment. British Journal of Cancer 109:3, pages 633-640.
Crossref
Crossref
LaMont J. Barlow, Mark J. Mann, Ketan K. Badani, Mitchell C. Benson & James M. McKiernan. (2010) Has the Advent of Minimally Invasive Surgery Altered the Risk Profile of Patients Undergoing Prostatectomy?. Urology 75:2, pages 427-430.
Crossref
Crossref
H.F. L’Eplattenier, B. Klem, E. Teske, F.J. van Sluijs, S.A. van Nimwegen & J. Kirpensteijn. (2008) Preliminary results of intraoperative photodynamic therapy with 5-aminolevulinic acid in dogs with prostate carcinoma. The Veterinary Journal 178:2, pages 202-207.
Crossref
Crossref
Supriya Shah, Janet K. Hess-Wilson, Siobhan Webb, Hannah Daly, Sonia Godoy-Tundidor, Jae Kim, Joanne Boldison, Yehia Daaka & Karen E. Knudsen. (2008) 2,2-Bis(4-Chlorophenyl)-1,1-Dichloroethylene Stimulates Androgen Independence in Prostate Cancer Cells through Combinatorial Activation of Mutant Androgen Receptor and Mitogen-Activated Protein Kinase Pathways. Molecular Cancer Research 6:9, pages 1507-1520.
Crossref
Crossref
T. Jäger, H. Rübben & C. Börgermann. (2007) Differenzialtherapie des ProstatakarzinomsDifferential therapy of prostate cancer. Der Internist 48:12, pages 1382-1388.
Crossref
Crossref
Michael Mitterberger, Germar‐Michael Pinggera, Leo Pallwein, Johann Gradl, Ferdinand Frauscher, Georg Bartsch, Hannes Strasser, Thomas Akkad & Wolfgang Horninger. (2007) The value of three‐dimensional transrectal ultrasonography in staging prostate cancer. BJU International 100:1, pages 47-50.
Crossref
Crossref
Khatami Ali, Aus Gunnar, Damber Jan-Erik, Lilja Hans, Lodding Pär & Hugosson Jonas. (2007) PSA doubling time predicts the outcome after active surveillance in screening-detected prostate cancer: Results from the European randomized study of screening for prostate cancer, Sweden section. International Journal of Cancer 120:1, pages 170-174.
Crossref
Crossref
Yelena B. Wetherill, Janet K. Hess-Wilson, Clay E.S. Comstock, Supriya A. Shah, C. Ralph Buncher, Larry Sallans, Patrick A. Limbach, Sandy Schwemberger, George F. Babcock & Karen E. Knudsen. (2006) Bisphenol A facilitates bypass of androgen ablation therapy in prostate cancer. Molecular Cancer Therapeutics 5:12, pages 3181-3190.
Crossref
Crossref